Posted on May 18, 2011 by Joel Shpigel R.Ph.

Taking Diabetes Drug Actos Could Lead to a Higher Risk of Developing Bladder Cancer

 

More research is needed but over a period of five years, 138 instances of bladder cancer were reported from patients taking diabetes medications. Over 28 of these patients were taking Actos (pioglitazone). This suggests a "disproportionate risk" in comparison with other anti-diabetics, said study author Dr. Elisabetta Poluzzi of the University of Bologna in Italy."Disproportion is indicative of possible risk," Poluzzi added, "not of an actual risk."

The FDA has said patients should not stop taking Actos unless told to do so by their doctor.

 

Tags: , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.diabetespharmacist.com/admin/trackback/249008
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.